In this episode of The Cole Memo, Cole breaks down a press release from MMJ BioPharma that's shaking up the cannabis world. The company accuses the DEA of obstruction, selective enforcement, and unconstitutional practices—and it has people speculating that federal rescheduling might finally be near. But will it actually help? Cole analyzes what’s in the press release, highlights comments from AG Pam Bondi, and plays clips from MMJ’s CEO via The Dales Report. Plus, what might DEA Administrator nominee Terrence Cole’s past statements reveal about what’s next? It’s a timely, cautious conversation about what reform might actually look like. Watch video version or read full show notes below: https://thecolememo.com/2025/06/04/e207/